A RETROSPECTIVE ANALYSIS OF EFFICACY OF HEMOADSORPTION (CYTOSORB®) IN REFRACTORY SEPTIC SHOCK PATIENTS AS AN ADJUVANT

Dysregulated response of cytokines can result in hyper-inflammatory conditions called cytokine storm,commonly seen in sepsis and septicshock..The current study assessed hemoadsorption device - CytoSorb® for its efficiency as an adjuvant in treating patients suffering from septicshock. Total 8 patients enrolled were subjected to hemoadsorption therapy along with the standard treatment.The results of the study revealedsignificant improvement in clinical and haemodynamic parameters before and after initiation of CytoSorb® therapy. Out of 8 patients, 6 showed apositive outcome while 2 did not survive.The results of this study show that the use of hemoadsorption therapy can be considered in critically illICU patients as a safe and effective adjuvant therapy along with the standard treatment for a better outcome in patients.